• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌肿瘤微环境中的CD8 T细胞耗竭

CD8 T cell exhaustion in the tumor microenvironment of breast cancer.

作者信息

Xie Hanghang, Xi Xiaowei, Lei Ting, Liu Hongli, Xia Zhijia

机构信息

Xi'an People's Hospital (Xi'an Fourth Hospital), Affiliated People's Hospital of Northwest University, Xi'an, China.

Technical University of Munich (TUM) School of Medicine and Health, Munich, Germany.

出版信息

Front Immunol. 2024 Dec 9;15:1507283. doi: 10.3389/fimmu.2024.1507283. eCollection 2024.

DOI:10.3389/fimmu.2024.1507283
PMID:39717767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11663851/
Abstract

CD8+ T cells are crucial cytotoxic components of the tumor immune system. In chronic inflammation, they become low-responsive, a state known as T cell exhaustion (TEX). The aim of immune checkpoint blockade is to counteract TEX, yet its dynamics in breast cancer remain poorly understood. This review defines CD8+ TEX and outlines its features and underlying mechanisms. It also discusses the primary mechanisms of CD8+ TEX in breast cancer, covering inhibitory receptors, immunosuppressive cells, cytokines, transcriptomic and epigenetic alterations, metabolic reprogramming, and exosome pathways, offering insights into potential immunotherapy strategies for breast cancer.

摘要

CD8+ T细胞是肿瘤免疫系统中至关重要的细胞毒性成分。在慢性炎症中,它们会变得反应低下,这种状态被称为T细胞耗竭(TEX)。免疫检查点阻断的目的是对抗TEX,但其在乳腺癌中的动态变化仍知之甚少。本综述定义了CD8+ TEX,并概述了其特征和潜在机制。它还讨论了乳腺癌中CD8+ TEX的主要机制,包括抑制性受体、免疫抑制细胞、细胞因子、转录组和表观遗传改变、代谢重编程以及外泌体途径,为乳腺癌潜在的免疫治疗策略提供了见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5020/11663851/353a322a885f/fimmu-15-1507283-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5020/11663851/353a322a885f/fimmu-15-1507283-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5020/11663851/353a322a885f/fimmu-15-1507283-g001.jpg

相似文献

1
CD8 T cell exhaustion in the tumor microenvironment of breast cancer.乳腺癌肿瘤微环境中的CD8 T细胞耗竭
Front Immunol. 2024 Dec 9;15:1507283. doi: 10.3389/fimmu.2024.1507283. eCollection 2024.
2
CD8 T cell exhaustion and its regulatory mechanisms in the tumor microenvironment: key to the success of immunotherapy.肿瘤微环境中 CD8 T 细胞耗竭及其调控机制:免疫治疗成功的关键。
Front Immunol. 2024 Sep 20;15:1476904. doi: 10.3389/fimmu.2024.1476904. eCollection 2024.
3
CD8 T-cell exhaustion: Impediment to triple-negative breast cancer (TNBC) immunotherapy.CD8 T细胞耗竭:三阴性乳腺癌(TNBC)免疫治疗的障碍。
Biochim Biophys Acta Rev Cancer. 2024 Nov;1879(6):189193. doi: 10.1016/j.bbcan.2024.189193. Epub 2024 Oct 15.
4
Glycosylphosphatidylinositol anchor biosynthesis pathway-based biomarker identification with machine learning for prognosis and T cell exhaustion status prediction in breast cancer.基于糖基磷脂酰肌醇锚生物合成途径的生物标志物识别,利用机器学习预测乳腺癌的预后和T细胞耗竭状态
Front Immunol. 2024 Jul 2;15:1392940. doi: 10.3389/fimmu.2024.1392940. eCollection 2024.
5
Evaluating the immunologically "cold" tumor microenvironment after treatment with immune checkpoint inhibitors utilizing PET imaging of CD4 + and CD8 + T cells in breast cancer mouse models.利用 PET 成像评估乳腺癌小鼠模型中免疫检查点抑制剂治疗后 CD4+和 CD8+T 细胞的免疫“冷”肿瘤微环境。
Breast Cancer Res. 2024 Jun 25;26(1):104. doi: 10.1186/s13058-024-01844-3.
6
NOX4 modulates breast cancer progression through cancer cell metabolic reprogramming and CD8 T cell antitumor activity.NOX4通过癌细胞代谢重编程和CD8 T细胞抗肿瘤活性调节乳腺癌进展。
Front Immunol. 2025 Feb 7;16:1534936. doi: 10.3389/fimmu.2025.1534936. eCollection 2025.
7
Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer.T 淋巴细胞的独特耗竭特征塑造了肿瘤免疫微环境,这对非小细胞肺癌患者具有治疗意义。
J Immunother Cancer. 2021 Dec;9(12). doi: 10.1136/jitc-2021-002780.
8
CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8 T Cells.CD39 表达定义了肿瘤浸润 CD8 T 细胞中的细胞耗竭。
Cancer Res. 2018 Jan 1;78(1):115-128. doi: 10.1158/0008-5472.CAN-16-2684. Epub 2017 Oct 24.
9
TOX-expressing terminally exhausted tumor-infiltrating CD8 T cells are reinvigorated by co-blockade of PD-1 and TIGIT in bladder cancer.在膀胱癌中,共阻断 PD-1 和 TIGIT 可重新激活表达 TOX 的终末耗竭肿瘤浸润 CD8 T 细胞。
Cancer Lett. 2021 Feb 28;499:137-147. doi: 10.1016/j.canlet.2020.11.035. Epub 2020 Nov 27.
10
Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer.肿瘤浸润淋巴细胞亚群在乳腺癌中的预后和治疗作用。
Cancer Metastasis Rev. 2021 Jun;40(2):519-536. doi: 10.1007/s10555-021-09968-0. Epub 2021 May 7.

引用本文的文献

1
Single-cell profiling delineates the tumor microenvironment and immunological networks in patient-derived uterine leiomyosarcoma.单细胞分析描绘了患者来源的子宫平滑肌肉瘤中的肿瘤微环境和免疫网络。
Front Immunol. 2025 Aug 29;16:1653096. doi: 10.3389/fimmu.2025.1653096. eCollection 2025.
2
Mechanisms and therapeutic strategies of macrophages and neutrophils inducing ulcerative colitis progression.巨噬细胞和中性粒细胞诱导溃疡性结肠炎进展的机制及治疗策略
Front Immunol. 2025 Aug 29;16:1615340. doi: 10.3389/fimmu.2025.1615340. eCollection 2025.
3
Microbiome-macrophage crosstalk in the tumor microenvironment: implications for oral squamous cell carcinoma progression and therapy.

本文引用的文献

1
Breast cancer cell derived exosomes reduces glycolysis of activated CD8 + T cells in a AKT-mTOR dependent manner.乳腺癌细胞衍生的外泌体以AKT-mTOR依赖的方式降低活化的CD8 + T细胞的糖酵解作用。
Cell Biol Int. 2025 Jan;49(1):45-54. doi: 10.1002/cbin.12241. Epub 2024 Sep 16.
2
Tumor-derived exosomal ICAM1 promotes bone metastasis of triple-negative breast cancer by inducing CD8+ T cell exhaustion.肿瘤来源的外泌体 ICAM1 通过诱导 CD8+T 细胞耗竭促进三阴性乳腺癌骨转移。
Int J Biochem Cell Biol. 2024 Oct;175:106637. doi: 10.1016/j.biocel.2024.106637. Epub 2024 Aug 13.
3
T cell exhaustion and senescence for ovarian cancer immunotherapy.
肿瘤微环境中微生物群与巨噬细胞的相互作用:对口腔鳞状细胞癌进展和治疗的影响
Front Immunol. 2025 Aug 29;16:1651837. doi: 10.3389/fimmu.2025.1651837. eCollection 2025.
4
The Underlying Mechanisms and Emerging Strategies to Overcome Resistance in Breast Cancer.克服乳腺癌耐药性的潜在机制与新兴策略
Cancers (Basel). 2025 Sep 8;17(17):2938. doi: 10.3390/cancers17172938.
5
Progress in targeting tumor-associated macrophages in cancer immunotherapy.癌症免疫治疗中靶向肿瘤相关巨噬细胞的研究进展。
Front Immunol. 2025 Aug 27;16:1658795. doi: 10.3389/fimmu.2025.1658795. eCollection 2025.
6
Immunosuppressive tumor microenvironment and advance in immunotherapy in melanoma bone metastasis.黑色素瘤骨转移中的免疫抑制性肿瘤微环境与免疫治疗进展
Front Immunol. 2025 Aug 27;16:1608215. doi: 10.3389/fimmu.2025.1608215. eCollection 2025.
7
Dual roles of innate immune cells and cytokines in shaping the breast cancer microenvironment.天然免疫细胞和细胞因子在塑造乳腺癌微环境中的双重作用。
Front Immunol. 2025 Aug 20;16:1654947. doi: 10.3389/fimmu.2025.1654947. eCollection 2025.
8
Extracellular vesicles in osteoarthritis: mechanisms, therapeutic potential, and diagnostic applications.骨关节炎中的细胞外囊泡:作用机制、治疗潜力及诊断应用
Front Immunol. 2025 Aug 13;16:1595095. doi: 10.3389/fimmu.2025.1595095. eCollection 2025.
9
Tumor-infiltrating lymphocytes in NSCLC: from immune surveillance to immunotherapy.非小细胞肺癌中的肿瘤浸润淋巴细胞:从免疫监视到免疫治疗
Front Immunol. 2025 Jul 25;16:1610998. doi: 10.3389/fimmu.2025.1610998. eCollection 2025.
10
Revolutionizing cervical cancer treatment: single-cell sequencing of tumor EPCs and immune checkpoints to assess drug sensitivity and optimize therapy.变革宫颈癌治疗:肿瘤内皮祖细胞和免疫检查点的单细胞测序以评估药物敏感性并优化治疗
Front Immunol. 2025 Jul 24;16:1574174. doi: 10.3389/fimmu.2025.1574174. eCollection 2025.
T 细胞耗竭和衰老与卵巢癌免疫治疗。
Semin Cancer Biol. 2024 Sep;104-105:1-15. doi: 10.1016/j.semcancer.2024.07.001. Epub 2024 Jul 18.
4
Glycosylphosphatidylinositol anchor biosynthesis pathway-based biomarker identification with machine learning for prognosis and T cell exhaustion status prediction in breast cancer.基于糖基磷脂酰肌醇锚生物合成途径的生物标志物识别,利用机器学习预测乳腺癌的预后和T细胞耗竭状态
Front Immunol. 2024 Jul 2;15:1392940. doi: 10.3389/fimmu.2024.1392940. eCollection 2024.
5
Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance.孕激素驱动的 B7-H4 有助于肿瘤-胎儿免疫耐受。
Cell. 2024 Aug 22;187(17):4713-4732.e19. doi: 10.1016/j.cell.2024.06.012. Epub 2024 Jul 4.
6
TWIST1 Drives Cytotoxic CD8+ T-Cell Exhaustion through Transcriptional Activation of (PD-L1) Expression in Breast Cancer Cells.TWIST1通过转录激活乳腺癌细胞中程序性死亡配体1(PD-L1)的表达来驱动细胞毒性CD8 + T细胞耗竭。
Cancers (Basel). 2024 May 22;16(11):1973. doi: 10.3390/cancers16111973.
7
Antitumor progenitor exhausted CD8 T cells are sustained by TCR engagement.肿瘤杀伤祖细胞耗竭的 CD8 T 细胞受 TCR 结合维持。
Nat Immunol. 2024 Jun;25(6):1046-1058. doi: 10.1038/s41590-024-01843-8. Epub 2024 May 30.
8
Immunometabolism of CD8 T cell differentiation in cancer.癌症中 CD8 T 细胞分化的免疫代谢。
Trends Cancer. 2024 Jul;10(7):610-626. doi: 10.1016/j.trecan.2024.03.010. Epub 2024 Apr 30.
9
IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer.IL1R2阻断可减轻三阴性乳腺癌中的免疫抑制并增强抗PD-1疗效。
Cancer Res. 2024 Jul 15;84(14):2282-2296. doi: 10.1158/0008-5472.CAN-23-3429.
10
NR4a1/2 deletion promotes accumulation of TCF1 stem-like precursors of exhausted CD8 T cells in the tumor microenvironment.NR4a1/2 缺失促进肿瘤微环境中耗尽的 CD8 T 细胞中 TCF1 干细胞样前体的积累。
Cell Rep. 2024 Mar 26;43(3):113898. doi: 10.1016/j.celrep.2024.113898. Epub 2024 Mar 6.